Advertisement

Topics

Ustekinumab for the Treatment of Giant Cell Arteritis

2016-11-07 08:56:34 | BioPortfolio

Published on BioPortfolio: 2016-11-07T08:56:34-0500

Clinical Trials [610 Associated Clinical Trials listed on BioPortfolio]

Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis

Giant cell arteritis (GCA) is the most common form of vasculitis after age 50. It is a vasculitis affecting the large vessels, in particular the aorta and its collateral vessels, especiall...

Hydroxychloroquine in Giant Cell Arteritis

Cortico-dependence is frequent in giant cell arteritis patients, and no drugs has proved its ability to prevent corticodependence. Hydrocychloroquine is a well tolerated immunomodulatory d...

HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis

Hypothesis: In giant cell arteritis (GCA), a short initial treatment with anti-TNF may allow a faster decrease of steroids dosage and therefore avoid some of the adverse events of steroids...

A Study of RoActemra/Actemra (Tocilizumab) in Patients With Giant Cell Arteritis

This multicenter, randomized, double-blind, placebo-controlled study will evaluate the efficacy and safety of RoActemra/Actemra (tocilizumab) in patients with giant cell arteritis. Patient...

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis

The purpose of this study is to evaluate the safety and efficacy (effectiveness) of Infliximab (Remicade) in patients with Giant Cell Arteritis. Infliximab (Remicade) targets specific pro...

PubMed Articles [16016 Associated PubMed Articles listed on BioPortfolio]

Giant---cell arteritis---related mortality in France: A multiple---cause---of---death analysis Giant---cell arteritis---related mortality in France.

Giant---cell arteritis (GCA) is a large vessel vasculitis. Data regarding mortality are controversial. We describe the mortality data of the French death certificates for the period of 2005 to 2014.

The role of biologics in the treatment of giant cell arteritis.

Giant cell arteritis is a vasculitis of large and middle-sized arteries that affects individuals older than 50 years. Although glucocorticoids remain the mainstay in the treatment of this vasculitis, ...

Update on giant cell arteritis.

Giant cell arteritis (GCA) is a challenging condition to manage because of the potential for acute irreversible vision loss and corticosteroid-related morbidity. Recent developments offer the potentia...

Additional costs of polymyalgia rheumatica with giant-cell arteritis.

To assess and compare direct costs between patients with giant-cell arteritis (GCA) associated or not with polymyalgia rheumatic (PMR), and to identify the additional cost drivers due to PMR.

The Association of Gout with Incident Giant Cell Arteritis in Older adults.

To assess whether gout is associated with a higher or lower risk of a new diagnosis of giant cell arteritis (GCA) in older adults, adjusting for known risk factors of GCA.

Medical and Biotech [MESH] Definitions

A non-neoplastic inflammatory lesion, usually of the jaw or gingiva, containing large, multinucleated cells. It includes reparative giant cell granuloma. Peripheral giant cell granuloma refers to the gingiva (giant cell epulis); central refers to the jaw.

A systemic autoimmune disorder that typically affects medium and large ARTERIES, usually leading to occlusive granulomatous vasculitis with transmural infiltrate containing multinucleated GIANT CELLS. The TEMPORAL ARTERY is commonly involved. This disorder appears primarily in people over the age of 50. Symptoms include FEVER; FATIGUE; HEADACHE; visual impairment; pain in the jaw and tongue; and aggravation of pain by cold temperatures. (From Adams et al., Principles of Neurology, 6th ed)

Tumors of bone tissue or synovial or other soft tissue characterized by the presence of giant cells. The most common are giant cell tumor of tendon sheath and GIANT CELL TUMOR OF BONE.

A syndrome in the elderly characterized by proximal joint and muscle pain, high erythrocyte sedimentation rate, and a self-limiting course. Pain is usually accompanied by evidence of an inflammatory reaction. Women are affected twice as commonly as men and Caucasians more frequently than other groups. The condition is frequently associated with GIANT CELL ARTERITIS and some theories pose the possibility that the two diseases arise from a single etiology or even that they are the same entity.

Multinucleated cells (fused macrophages) seen in granulomatous inflammations such as tuberculosis, syphilis, sarcoidosis, and deep fungal infections. They resemble foreign-body giant cells (GIANT CELLS, FOREIGN BODY) but Langhans giant cells contain less chromatin and their nuclei are arranged peripherally in a horseshoe-shaped pattern. Langhans giant cells occur frequently in delayed hypersensitivity.

More From BioPortfolio on "Ustekinumab for the Treatment of Giant Cell Arteritis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial